tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Soumit Roy, 65 are a BUY (80.25%), 1 are a SELL (1.23%), 15 are a HOLD (18.52%).
Analyst Soumit Roy, currently employed at JONESTRADING, carries an average stock price target met ratio of 37.07% that have a potential upside of 31.67% achieved within 134 days.
Soumit Roy’s has documented 144 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EDIT, Editas Medicine at 10-Mar-2026.
Analyst best performing recommendations are on CGEM (CULLINAN ONCOLOGY LLC).
The best stock recommendation documented was for CGEM (CULLINAN ONCOLOGY LLC) at 4/16/2024. The price target of $26 was fulfilled within 13 days with a profit of $8.68 (50.12%) receiving and performance score of 38.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 31-Oct-2023
$23
$-2.59 (-10.12%)
$23
2 years 4 months 5 days ago
(10-May-2024)
5/8 (62.5%)
$-2.36 (-9.31%)
108
Sell Since 01-Mar-2022
$26
$0.41 (1.60%)
2 years 4 months 16 days ago
(30-Apr-2024)
2/7 (28.57%)
$0.73 (2.89%)
324
Buy Since 17-Sep-2018
$22
2 years 4 months 16 days ago
(30-Apr-2024)
2/3 (66.67%)
$2.24 (11.34%)
67
Buy Since 15-Mar-2023
$23
2 years 4 months 16 days ago
(30-Apr-2024)
4/6 (66.67%)
$8.58 (59.50%)
352
Buy Since 29-Apr-2024
$25.6
$0.01 (0.04%)
2 years 4 months 17 days ago
(29-Apr-2024)
0/1 (0%)
$0.32 (1.27%)
What Year was the first public recommendation made by Soumit Roy?
